The challenge of diabetes home control in COVID-19 times: Proof is in the pudding.


Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 02 06 2020
revised: 02 08 2020
accepted: 17 08 2020
pubmed: 28 8 2020
medline: 26 11 2020
entrez: 28 8 2020
Statut: ppublish

Résumé

SARS-CoV-2 pandemic had changed self-care in diabetes. The aim of this work is to analyze the effect of lockdown on glycemic control in people with type 1 diabetes on multiple daily insulin injections using FGM. During lockdown no deleterious effect on glycemic control measured by FGM.

Identifiants

pubmed: 32853692
pii: S0168-8227(20)30632-X
doi: 10.1016/j.diabres.2020.108379
pmc: PMC7445133
pii:
doi:

Substances chimiques

Blood Glucose 0
Insulin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108379

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declared that there is no conflict of interest.

Références

N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Diabetes Care. 2020 Jul;43(7):1427-1432
pubmed: 32409501
Diabetes Metab Syndr. 2020 May - Jun;14(3):211-212
pubmed: 32172175
Diabetes Ther. 2020 Jun;11(6):1369-1379
pubmed: 32395187
JAMA. 2017 Jan 24;317(4):371-378
pubmed: 28118453
BMJ Open Diabetes Res Care. 2020 Mar;8(1):
pubmed: 32198165
Diabetes Technol Ther. 2020 May 12;:
pubmed: 32396400
Diabetes Metab. 2020 Sep;46(4):265-271
pubmed: 32447101
Diabetes Care. 2019 Aug;42(8):1593-1603
pubmed: 31177185
Diabetologia. 2020 Aug;63(8):1440-1452
pubmed: 32405783
Diabetes Metab Res Rev. 2020 Mar 31;:e33213321
pubmed: 32233018
Diabetes Technol Ther. 2020 Jun;22(6):444-448
pubmed: 32396395
JAMA. 2017 Jan 24;317(4):379-387
pubmed: 28118454

Auteurs

Laura Cotovad-Bellas (L)

Endocrinology and Nutrition Unit, University Hospital of Ferrol, Spain, Avda de la Residencia S/N, Ferrol, 15401 La Coruña, Spain.

Cristina Tejera-Pérez (C)

Endocrinology and Nutrition Unit, University Hospital of Ferrol, Spain, Avda de la Residencia S/N, Ferrol, 15401 La Coruña, Spain. Electronic address: cristina.tejera.perez@sergas.es.

Alma Prieto-Tenreiro (A)

Endocrinology and Nutrition Unit, University Hospital of Ferrol, Spain, Avda de la Residencia S/N, Ferrol, 15401 La Coruña, Spain.

Ana Sánchez-Bao (A)

Endocrinology and Nutrition Unit, University Hospital of Ferrol, Spain, Avda de la Residencia S/N, Ferrol, 15401 La Coruña, Spain.

Diego Bellido-Guerrero (D)

Endocrinology and Nutrition Unit, University Hospital of Ferrol, Spain, Avda de la Residencia S/N, Ferrol, 15401 La Coruña, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH